http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0760370-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9575aa9deffac891c58962bae1ee889
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-06
filingDate 1996-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99090c7c243b1822bc564896fac8b7d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a24830f33026d3261931b53048635b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e320bfd6ccfb4fc898ace3df20518802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68e8d9af8bbd10b750c7d9cce7134b39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73dc486e876ba3574976b439d591d324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef6ff699d8c68279254ec714a30fbea8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6eafd5cb8be888c76038592f8125239
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e499171e46f62b607d50c4655ebbdde9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a6ee3a6a91dd8c7819141b50d4054a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fa47d873f15ad2f14b2f5fe5ba2cfcb
publicationDate 1997-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0760370-A4
titleOfInvention NEW CARBAPENEMIC DERIVATIVES
abstract Novel carbapenem derivatives represented by general formula (I) which have an optionally substituted imidazo[5,1-b]thiazolium-6-ylmethyl group at the 2-position. The compounds have a broad and potent antibacterial activity on Gram-positive bacteria and Gram-negative bacteria including Pseudomonas aeruginosa and show a potent antibacterial effect on various β-lactamase-producing bacteria and MRSA and an extremely high DHP-1 stability.
priorityDate 1995-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9507912-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06211908-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05230573-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571976
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13293131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423088
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID287

Total number of triples: 34.